Le Infezioni in Medicina, n. 1, 57-61, 2014 Casi clinici Usefulness of (1→3)-b-D glucan in early diagnosing Case reports Pneumocystis jirovecii : a case report Utilità del (1→3)-b-D glucano nella diagnosi precoce di polmonite da Pneumocystis jirovecii: un caso clinico

Mustafa Altay Atalay1, Ayse Nedret Koc1, Leyla Gul Kaynar2, Melek Inci3, Fatma Filiz Kasap Tekinsen1, Bulent Eser2 1Department of Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey; 2Department of Hematology and Oncology, Faculty of Medicine, Erciyes University, Kayseri, Turkey: 3Department of Clinical Microbiology, Faculty of Medicine, MustafaKemal University, Hatay, Turkey

n INTRODUCTION measure serum BDG and galactomannan levels in immunocompromised patients and start pre- neumocystis jirovecii pneumoniae (PJP) is emptive therapy based on the results. We re- a well-known af- port an HIV-seronegative patient with acute P fecting immunocompromised hosts, es- lymphoblastic leukaemia (ALL) who devel- pecially patients infected with HIV. However, oped PJP, correlated with increasing serum with the rising number of patients receiving im- BDG levels. munosuppressive therapy, PJP is being increas- ingly recognized in immunosuppressed hosts who are not infected with HIV [1]. Invasive di- n CASE REPORT agnostic techniques such as BAL or trans- bronchial lung biopsy and specific staining of A 23-year-old male was admitted to the haema- cyst and/or trophozoites are the gold standard tological ward of the Erciyes University Hospi- for PJP diagnosis [2]. tal in September 2011 with fever and neutrope- BDG, one of the major components of the cyst nia and diagnosed with acute lymphoblastic wall of P. jirovecii, can be a serological marker leukaemia (ALL). The patient was treated with for the diagnosis and monitoring of PJP; some cycles of four Hyper-CVAD/ MTX-Ara-C (cy- reports have also supported this evidence [2-4]. clophosphamide, vincristine, doxorubicin, and (1→3) b-D-glucan (BDG) composes a portion of dexamethasone/methotrexate-cytarabine) the cell wall of most fungi, including Candida, chemotherapy and achieved complete remis- Aspergillus, and other and moulds such sion. Two years after the diagnosis, he com- as , Fusarium, Penicillium, plained of progressive dyspnea for three Cephalosporium, and Pneumocystis jiroveci [5]. months and fever with chills for two days. The serum level of BDG may be useful as a di- Cough and sputum were observed. Physical ex- agnostic and therapeutic indicator [6]. For the amination revealed a temperature of 38.6 ºC, early detection of fungal infection, we routinely respiratory rate of 25 breaths·min-1 and diffuse rales predominantly in the middle and lower chest. On laboratory examination, there was a Corresponding author severe neutropenia (white blood cell count Mustafa Altay Atalay [WBC] 1.07/mm3 and absolute neutrophil E-mail: [email protected] count 430/mm3). Initial chest film showed bilat-

57 2014 were sterile; smears for acid-fast bacilli and tests for viral antibodies were both negative. Serology for HIV was negative. A bron- choscopy with bronchoalveolar lavage was per- formed, but biopsy could not be carried out be- cause of decreasing oxygen saturation. My- cobacterial and mycologic cultures of BAL were negative. Giemsa and immunofluorescence staining of the BAL detected the existence of P. jiroveci in the lungs. The patient was therefore diagnosed with PJP. For the detection of P. jirovecii, a 10-mL BAL fluid was centrifuged at 1,875 g for 10 min., and a smear was microscopically examined for the presence of P. jirovecii with Giemsa stain and immunofluorescence stain (Cellabs Diagnostics Figure 1 - Giemsa staining (x 1000) of P. jirovecii cyst Pty. Ltd. Sydney, Australia) following the rec- containing up to 8 intracystic bodies. ommendations of the manufacturer. Seven days after admission, in Giemsa staining we saw P. jirovecii cysts containing up to eight in- tracystic bodies (Figure 1) and in immunofluo- rescence staining P. jirovecii exhibited bright, apple-green fluorescence of the round, thick- walled cysts and pleomorphic trophozoites in contrast to the reddish-brown colour of coun- terstained material (Figure 2). Laboratory values showed rising LDH with a maximum of 621 IU/L (normal 100-245 IU/L). One day and five days after admission, the serum level of BDG was >500 pg/mL (normal range <60 pg/mL) and galactomannan assay in serum was negative. After detection of P. jirovecii, TMP-SMX was added intravenously. The high serum level of BDG was considerably reduced by treatment Figure 2 - Immunofluorescence staining (x 400) of P. with TMP-SMX. The fever subsided the follow- jirovecii, apple-green fluorescence of the round, thick-walled cysts and pleomorphic trophozoites. ing day and the clinical condition of the patient increasingly improved. He was discharged from the hospital and clinical follow up was eral infiltrates without evidence of pleural effu- suggested. sion. Bone marrow aspirate showed myeloid suppression and no significant increase in blast cells. n DISCUSSION He was treated initially with supplemental oxy- gen and intravenous clarithromycin plus ce- We reported herein a case of PJP occurring two fepime for seven days, but clarithromycin was years after a patient was diagnosed as having changed to levofloxacin because of allergic re- ALL, in which the serum level of BDG was use- action. However, his condition deteriorated ful as an early diagnostic and therapeutic indi- and fever persisted. cator. The patient received treatment with granulo- Invasive fungal diseases, as opportunistic infec- cyte colony stimulating factor (GCSF) until his tions, are common among haematological ma- neutrophil count recovered. Intravenous dex- lignancy and AIDS patients and account for a amethasone with aminophylline was adminis- growing number of nosocomial infections, par- tered intermittently to relieve his dyspnea and ticularly among organ transplant recipients and wheezing. Sputum, blood, and urine cultures other patients receiving immunosuppressive

58 2014 treatments [7]. PJP in humans is caused by P. patient, one day after admission, both serum jirovecii, which has recently been reclassified as levels of LDH and BDG were significantly high- a because its cell wall composition and er. As P. jirovecii is more closely related to fun- nucleotide sequences are more similar to those gi than to , the measurement of plasma of fungi [8]. PJP may occur in a variety of BDG, which is a cell wall constituent of fungi, haematological diseases, including non- may be useful for both the diagnosis and the Hodgkin’s lymphoma, chronic lymphocytic therapeutic monitoring of PCP [14]. The BDG leukaemia, acute leukaemia, chronic myeloid assay we used (Fungitell; Associates of Cape leukaemia, multiple myeloma, myelodysplastic Cod) is made from Limulus polyphemus found syndrome, Hodgkin’s disease and thrombocy- on the Atlantic coast of North America between topenia [9]. Florida and the Gulf of Maine. Our patient was diagnosed as having ALL ap- Certain fungal produce very low levels proximately two years before and was admit- of BDG and are not detected by the Fungitell as- ted to hospital with progressive dyspnea and say. These include the Cryptococcus as fever with chills. well as Zygomycetes such as Absidia, Mucor and Though fever, dry cough and progressive dys- Rhizopus [15]. Persat et al. reported that the pnea with pulmonary infiltrates of an alveolar BDG test would be the first valuable non-inva- pattern are typical of PJP, these manifestations sive serodiagnostic tool for P. jiroveci pneumo- are non-specific [10]. nia and would be particularly useful for pa- PJP may be difficult to diagnose owing to non- tients for whom bronchoscopy was sometimes specific symptoms and signs, concurrent use of problematic [3]. prophylactic drugs, and simultaneous infection Compared with infection caused by other with various organisms. Since Pneumocystis pathogens, PJP can be significantly overlooked, cannot be cultured, the diagnosis of PJP re- especially in the presence of neutropenia. Our quires microscopic examination in order to case developed PJP in the setting of febrile neu- identify P. jirovecii from a clinically relevant tropenia. source such as specimens of induced sputum, The patient received broad-spectrum antibi- BAL fluid or lung tissue [11]. BAL has tradi- otics as the initial empirical treatment. tionally been the definitive clinical sample. In conclusion, PJP should be considered in the However, the procedure to obtain the specimen early phase of febrile neutropenia in patients is invasive while the induced sputum sample is with haematological malignancies. We experi- not sensitive compared to BAL and lung tissue enced a case of PJP that was diagnosed by for detection of P. jiroveci [12]. Giemsa and immunofluorescence stains in We detected the existence of P. jiroveci in the BAL; also, the patient’s serum level of BDG was lung by Giemsa and immunofluorescence stain- useful as diagnostic and therapeutic indicator. ing of the BAL. With Giemsa stain P jirovecii We suggest that measuring BDG could be con- cysts are variably stained and intracystic bodies sidered as a primary modality for early diagno- are present in different numbers within the sis of PJP, especially for patients in whom bron- cysts. Mature cysts have eight intracystic bod- choscopy is problematic because of respiratory ies. Some cysts appear empty. Serum testing for status, or for those with negative sputum or the diagnosis of PJP has not yet been estab- bronchoscopic lavage sampling results for lished. Although an elevated serum LDH level whom the clinical suspicion for PJP remains has been noted in patients with PJP, it is likely high. Future studies should explore the rela- to be a reflection of the underlying lung inflam- tionship of this marker to clinical outcomes and mation and injury rather than a specific marker prognosis. for the disease. [13]. On the other hand, Obayashi et al. reported Keywords: Pneumocystis jirovecii pneumoniae, that, serum levels of LDH and BDG were sig- acute lymphoblastic leukaemia, (13)--D-glu- nificantly higher in PJP-positive patients. In our can.

59 2014 SUMMARY

Pneumocystis jirovecii pneumoniae (PJP) may be tum, blood, and urine cultures were negative; sme- difficult to diagnose. Since pneumocystis cannot ars for acid-fast bacilli and tests for viral antibodi- be cultured, the diagnosis of PJP requires micros- es were both negative. The microbiology study of copic examination to identify pneumocystis from the BAL with Giemsa and immunofluorescence induced sputum or bronchoalveolar lavage (BAL) staining, seven days after admission showed the fluid. In order to evaluate the usefulness of (13) ß- existence of P. jiroveci in the lungs. Further, one D-glucan (BDG) levels in the early diagnosis of day and five days after admission, (13) ß-D-glu- PJP, we describe the case of PJP in a 25-year-old can (BDG) levels were very high. The high serum male with acute lymphoblastic leukaemia (ALL) level of BDG considerably decreased after treat- admitted to hospital with progressive dyspnea ment with trimethoprim-sulfamethoxazole (TMP- and fever with chills. The patient was not infected SMX) and the clinical condition of the patient in- with human virus (HIV). Spu- creasingly improved.

RIASSUNTO

La polmonite da Pneumocystis jirovecii (PJP) può por- rato, del sangue e delle urine erano negativi; gli strisci re delle difficoltà diagnostiche. Infatti, in assenza di tec- per la ricerca di bacilli acido-alcol resistenti e i test per niche colturali per pneumocystis, la diagnosi di PJP ric- la ricerca di anticorpi virali erano entrambi negativi. hiede l’esame microscopico per l’identificazione di pneu- L’esame microbiologico del BAL con colorazione di Gi- mocystis dall’espettorato indotto o dal liquido di lavag- emsa e immunofluorescenza, condotto dopo sette giorni gio broncoalveolare (BAL). Al fine di valutare l’utilità dal ricovero metteva in luce la presenza di P. jiroveci nei dei livelli di (13) ß-D-glucano (BDG) nella diagnosi polmoni. Inoltre, dopo uno e cinque giorni dal ricovero precoce di PJP, nel presente articolo descriviamo un ca- i livelli di (13) ß-D-glucano (BDG) erano molto eleva- so di PJP occorso in un uomo di 25 anni affetto da leu- ti. L’alto livello sierico di BDG si è poi considerevol- cemia linfoblastica acuta (LLA) ricoverato in ospedale mente ridotto a seguito di trattamento con trimetop- con dispnea progressiva e febbre con brividi. Il paziente rim/sulfametossazolo (TMP-SMX) e le condizioni del non era affetto da HIV. Gli esami colturali dell’espetto- paziente sono progressivamente migliorate.

n REFERENCES tion based on plasma (1→3) b-D-glucan levels after liver transplantation. Infection 35, 346-351, 2007. [1] Cheng V.C., Hung I.F., Wu A.K., Tang B.S., Chu [6] Kawagishi N., Miyagi S., Satoh K., Akamatsu Y., C.M., Yuen K.Y. Lymphocyte surge as a marker for Sekiguchi S., Satomi S. Usefulness of beta-D glucan immunorestitution disease due to Pneumocystis in diagnosing Pneumocystis carinii pneumonia and jirovecii pneumonia in HIV-negative immunosup- monitoring its treatment in a living-donor liver- pressed hosts. Eur. J. Clin. Microbiol. Infect. Dis 23, transplant recipient. J. Hepatobiliary Pancreat. Surg. 512-514, 2004. 14, 308-311, 2007. [2] Nakamura H., Tateyama M., Tasato D., et al. Clin- [7] Alexander B. Diagnosis of fungal infection: new ical utility of serum b-d-glucan and KL-6 levels in technologies for the mycology laboratory. Transpl. Pneumocystis jirovecii pneumonia. Intern. Med. 48, Infectious Dis. 4 (Suppl. 3), 32-37, 2002. 195-202, 2009. [8] Lu J.J., Lee C.H. . J. For- [3] Persat F., Ranque S., Derouin F., Michel-Nquyen mos Med. Assoc. 107, 830-842, 2008. A., Picot S., Sulahian A. Contribution of the (1→3)-b- [9] Chang H., Yeh H.C., Su Y.C., Lee M.H. Pneumo- D-glucan assay for diagnosis of invasive fungal in- cystis jiroveci pneumonia in patients with non- fections. J. Clin. Microbiol. 46, 1009-1013, 2008. Hodgkin’s lymphoma receiving chemotherapy con- [4] Shimizu A., Oka H., Matsuda T., Ozaki S. (1→3) taining rituximab. J. Chin. Med. Assoc. 71, 579-582, b-D glucan is a diagnostic and negative prognostic 2008. marker for Pneumocystis carinii pneumonia in pa- [10] Thomas C.F., Limper A.H. Pneumocystis pneu- tients with connective tissue disease. Clin. Exp. monia. N. Engl. J. Med. 350, 2487-2498, 2004. Rheumatol. 23, 678-680, 2005. [11] Sadatomo Tasaka S., Hasegaw H., Kobayashi S., [5] Akamatsu N., Sugawara Y., Kaneko J., Tamura S., et al. Serum indicators for the diagnosis of pneumo- Makuuchi M. Preemptive treatment of fungal infec- cystis pneumonia. Chest 131, 1173-1180, 2007.

60 2014 [12] Pinlaor S., Mootsikapun P., Pinlaor P., et al. PCR (1→3)-beta-D-glucan measurement in diagnosis of diagnosis of Pneumocystis carinii on sputum and invasive deep and fungal febrile episodes. bronchoalveolar lavage samples in immuno-compro- Lancet 345, 17-20, 1995. mised patients. Parasitol. Res. 94, 213-218, 2004. [15] Odabasi Z., Paetznick V.L., Rodriguez J.R., Chen [13] Quist J., Hill A.R. Serum lactate dehydrogenase E., McGinnis M.R., Ostrosky-Zeichner L. Differences in Pneumocystis carinii pneumonia, tuberculosis, and in beta-glucan levels of culture supernatants of a va- bacterial pneumonia. Chest 108, 415-418, 1995. riety of fungi. Med. Mycol. 44, 267-272, 2006. [14] Obayashi T., Yoshida M., Mori T., et al. Plasma

61 2014